NEW YORK, March 10, 2023 /PRNewswire/ — The diffuse large B-cell lymphoma (DLBCL) therapeutics market size is forecast to grow by USD 2,061.88 million between 2022 and 2027, and the growth momentum will accelerate at a CAGR of 7.96% during the forecast period. The number of regulatory…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.